Scholar Rock Sees Unusually Large Options Volume (NASDAQ:SRRK)

Scholar Rock Holding Co. (NASDAQ:SRRK) was the recipient of unusually large options trading on Wednesday. Investors acquired 4,296 put options on the company. This represents an increase of approximately 1,387% compared to the average volume of 289 put options.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Wedbush reaffirmed an “outperform” rating and set a $23.00 price target on shares of Scholar Rock in a research report on Thursday, August 8th. HC Wainwright reaffirmed a “buy” rating and set a $30.00 target price on shares of Scholar Rock in a research report on Tuesday, June 25th. Finally, BMO Capital Markets boosted their price target on shares of Scholar Rock from $31.00 to $34.00 and gave the stock an “outperform” rating in a report on Friday, August 9th. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $26.43.

Institutional Trading of Scholar Rock

Institutional investors have recently modified their holdings of the business. Price T Rowe Associates Inc. MD raised its holdings in Scholar Rock by 16.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,321,471 shares of the company’s stock valued at $156,444,000 after acquiring an additional 1,149,519 shares during the period. Redmile Group LLC raised its stake in shares of Scholar Rock by 0.3% during the 1st quarter. Redmile Group LLC now owns 6,419,610 shares of the company’s stock valued at $114,012,000 after purchasing an additional 17,105 shares during the period. Vanguard Group Inc. lifted its holdings in Scholar Rock by 4.0% during the 1st quarter. Vanguard Group Inc. now owns 2,969,534 shares of the company’s stock worth $52,739,000 after purchasing an additional 114,550 shares in the last quarter. Bellevue Group AG boosted its stake in Scholar Rock by 1.5% in the 4th quarter. Bellevue Group AG now owns 2,168,925 shares of the company’s stock worth $40,776,000 after purchasing an additional 31,000 shares during the period. Finally, Goldman Sachs Group Inc. grew its holdings in Scholar Rock by 31.5% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,430,764 shares of the company’s stock valued at $26,898,000 after buying an additional 342,690 shares in the last quarter. 91.08% of the stock is currently owned by hedge funds and other institutional investors.

Scholar Rock Stock Up 0.5 %

Shares of NASDAQ SRRK opened at $8.65 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 6.04 and a quick ratio of 6.04. The stock has a market capitalization of $692.26 million, a PE ratio of -4.14 and a beta of 0.82. Scholar Rock has a one year low of $6.22 and a one year high of $21.17. The business’s fifty day moving average price is $8.90 and its 200-day moving average price is $11.05.

Scholar Rock (NASDAQ:SRRK) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.60) EPS for the quarter, beating the consensus estimate of ($0.61) by $0.01. During the same quarter in the previous year, the company earned ($0.47) EPS. On average, equities research analysts anticipate that Scholar Rock will post -2.39 EPS for the current year.

Scholar Rock Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.